Intercept Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2012
Total raised
- $55M
Investors
- 6
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc.Founded in 2002 in Morristown, US, Intercept Pharmaceuticals specializes in the development of therapies for serious liver diseases. The company has undergone strategic shifts in its business operations and was significantly impacted by its acquisition in May 2022 by Advanz Pharma Services (UK) Limited.00 mn from Advanz Pharma Services (UK) Limited.Intercept Pharmaceuticals focuses on developing and delivering innovative treatments for rare and serious liver diseases, with a notable emphasis on primary biliary cholangitis (PBC). The company's core product offerings include Ocaliva (obeticholic acid), the first and only FDA-approved farnesoid X receptor (FXR) agonist for PBC treatment. Ocaliva alleviates inflammation and prevents liver damage by reducing bile acid levels in the liver.65 mn.Intercept Pharmaceuticals aims to advance its Phase III POISE trial of obeticholic acid, a key treatment for patients unable to tolerate the current approved drug for PBC.S. through strategic collaborations and partnerships.
Who invested in Intercept Pharmaceuticals
6 investors across 2 rounds
See all investors in Intercept Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intercept Pharmaceuticals
Who invested in Intercept Pharmaceuticals?
Intercept Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intercept Pharmaceuticals raised?
Intercept Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Intercept Pharmaceuticals last raise money?
Intercept Pharmaceuticals's most recent round on record is a Series C, in Aug 2012.
What does Intercept Pharmaceuticals do?
Intercept Pharmaceuticals, Inc.
Where is Intercept Pharmaceuticals headquartered?
Intercept Pharmaceuticals is headquartered in Morristown, US.
Which VCs invest in companies like Intercept Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Intercept Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Intercept Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.